RecruitingNCT04469517

Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia

Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)


Sponsor

University Hospital, Essen

Enrollment

100 participants

Start Date

Aug 10, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Patients with hereditary hemorrhagic telangiectasia (HHT) suffer from an inherited disorder leading to systemic vascular malformations. Mutations in several genes of the transforming growth factor (TGF)-β superfamily pathway influence angiogenesis in patients with HHT. The genetic loss of ALK1 or ENG alone are not sufficient to induce AVMs; environmental insults that could trigger angiogenesis (e.g. wounding) are also needed. In this study it will be analyzed if hypoxic induced factors could have an influence on the disease HHT.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • diagnosed HHT (genetic testing and/ or fulfill at least 3 Curacao Criteria)
  • older than 17 years
  • ability to consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERhypoxic induced factors

hypoxic induced factors analyzed in blood sample


Locations(1)

University Hospital Essen

Essen, North Rhine-Westphalia, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04469517


Related Trials